Cargando…

SLC11A2: a promising biomarker and therapeutic target in ovarian cancer

Ovarian cancer has the highest mortality rate among gynecologic tumors, with a 5-year survival rate of less than 25%. There is an urgent need for early diagnosis and new drugs to reduce the disease burden of ovarian cancer. The aim of this study was to investigate the effectiveness of SLC11A2 as a t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Liming, Li, Xuemei, Lai, Huiling, Sun, Tingting, Li, Xiaohui, Wu, Linxiang, Wu, Chuling, Yao, Shuzhong, Ren, Yufeng, He, Shasha, Yang, Guofen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860018/ https://www.ncbi.nlm.nih.gov/pubmed/36670142 http://dx.doi.org/10.1038/s41598-022-26789-5

Ejemplares similares

Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer
por: Lai, Huiling, et al.
Publicado: (2022)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

Non-target genetic manipulation induces rhabdomyosarcoma in KrasPten-driven mouse model of ovarian cancer
por: Lai, Huiling, et al.
Publicado: (2020)

Necroptosis‐related regulatory pattern and scoring system for predicting therapeutic efficacy and prognosis in ovarian cancer
por: Lai, Huiling, et al.
Publicado: (2023)

Anaplastic carcinoma showing rhabdoid features combined with ovarian mucinous borderline cystadenoma: a case report and literature review
por: Sun, Tingting, et al.
Publicado: (2021)

SLC25A11 serves as a novel prognostic biomarker in liver cancer
por: Pan, Guoqiang, et al.
Publicado: (2020)

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
por: Hong, Ting, et al.
Publicado: (2021)

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
por: Zhang, Xiaoqian, et al.
Publicado: (2023)

Altered gene expression in slc4a11(−/−) mouse cornea highlights SLC4A11 roles
por: Alvarez, Bernardo V., et al.
Publicado: (2021)

WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer
por: Zhang, Chen, et al.
Publicado: (2021)

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
por: Wu, Zhenzhen, et al.
Publicado: (2022)

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
por: Sun, Tianshui, et al.
Publicado: (2020)

Association between the SLC6A11 rs2304725 and GABRG2 rs211037 polymorphisms and drug-resistant epilepsy: a meta-analysis
por: Hu, Xuemei, et al.
Publicado: (2023)

Promising Neuroimaging Biomarkers in Depression
por: Lai, Chien-Han
Publicado: (2019)

High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer
por: Qin, Lianzhi, et al.
Publicado: (2017)

The Role of SLC7A11 in Cancer: Friend or Foe?
por: Li, Sijia, et al.
Publicado: (2022)

Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer
por: Sun, Dan, et al.
Publicado: (2021)

Downregulation of lncRNA SLC7A11-AS1 decreased the NRF2/SLC7A11 expression and inhibited the progression of colorectal cancer cells
por: Wang, Tian, et al.
Publicado: (2023)

Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer
por: Ning, Li, et al.
Publicado: (2022)

STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53/SLC7A11 pathway
por: Yang, Youjing, et al.
Publicado: (2022)

Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
por: Chen, Zhixiang, et al.
Publicado: (2020)

High co‐expression of SLC7A11 and GPX4 as a predictor of platinum resistance and poor prognosis in patients with epithelial ovarian cancer
por: Wu, Xiaodong, et al.
Publicado: (2022)

Conditionally Immortal Slc4a11(−/−) Mouse Corneal Endothelial Cell Line Recapitulates Disrupted Glutaminolysis Seen in Slc4a11(−/−) Mouse Model
por: Zhang, Wenlin, et al.
Publicado: (2017)

The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients
por: Chen, Ming, et al.
Publicado: (2016)

Slc7a11 stimulates glutathione synthesis to preserve fatty acid metabolism in primary hepatocytes
por: Liu, Yifan, et al.
Publicado: (2023)

Circular RNAs: Promising Biomarkers for Human Diseases
por: Zhang, Zhongrong, et al.
Publicado: (2018)

Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients
por: Zhou, Chaoting, et al.
Publicado: (2021)

SLC17A9 expression levels in a pan‑cancer panel and validation of the role of SLC17A9 as a novel prognostic biomarker for osteosarcoma
por: Li, Junqing, et al.
Publicado: (2023)

SLC7A11, a potential immunotherapeutic target in lung adenocarcinoma
por: Shan, Qingqing, et al.
Publicado: (2023)

Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma
por: Fang, Xiangming, et al.
Publicado: (2023)

SRT2183 impairs ovarian cancer by facilitating autophagy
por: Sun, Tingting, et al.
Publicado: (2020)

SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
por: Zhou, Jie, et al.
Publicado: (2020)

lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCF(β-TRCP)-Mediated Degradation of NRF2 in Pancreatic Cancer
por: Yang, Qingzhu, et al.
Publicado: (2020)

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer
por: Dai, Wumin, et al.
Publicado: (2021)

Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer
por: Lin, Yi, et al.
Publicado: (2022)

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer
por: Ma, Yiming, et al.
Publicado: (2022)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells
por: Yan, Yuelong, et al.
Publicado: (2023)

MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
por: Pal, Manish K., et al.
Publicado: (2015)

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
por: Chen, Jingxuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2irnliuv7rimr012koiumbqhj0